Open Uncontrolled Cohort Study to Assess the Impact of Sibutramine-Assisted Weight Loss in Sleep Apnea in Men

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000330640

Enrollment

100

Registered

2005-09-07

Start date

2002-06-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sibutramine Assisted Weight Loss Programme. Sibutrmaine(Reductil)10-15 mg plus an exercise progrmamme and an dietary intervention for 6 months.

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

Moderate to Severe Obstructive Sleep Apnea male subjects with obesity (Body Mass Index 30-38 kg/m2).

Exclusion criteria

Signficant cardiovascular, respiratroy, metabolic ,renal, gastrointestinal or psychiatric disorder. Recent use of Continuous Positive Airway Pressure (CPAP) or upper airway surgery.

Outcome results